PVLAPalvella Therapeutics, Inc.
$138.94+139% 1Y
$138.94
$56.6952 weeks$158.19
Is it growing?
Mixed
1 good, 1 to watch, 1 without dataNeither accelerating nor breaking down: revenue growing +117% year on year, but operating margin narrowing (−1674.6 points).
Revenue trend+117% in a year
Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: −13% a year.
Margin direction−1674.6 points operating
Trailing-twelve-month operating margin, -1629.9% now against 44.8% a year earlier.
All from SEC EDGAR, as of Mar 31, 2026.
Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.
On our screens:Most shorted stocks
Biotechnology
The closest names by size in the same industry